Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Rutherford Diagnostics is going to revolutionise healthcare across the globe utilising genomic sequencing, personalised screening and innovative diagnostic technologies.
Rutherford Diagnostics is going to deliver a new healthcare paradigm supporting best possible healthcare outcomes through prediction, prevention and earliest possible detection of disease.
By utilising and developing innovative technologies, such as genomic sequencing, personalised screening and state-of-the-art diagnostics to reduce levels of acute illness and support good health, Rutherford Diagnostics will revolutionise healthcare.